A detailed history of California Public Employees Retirement System transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 371,638 shares of REGN stock, worth $281 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
371,638
Previous 376,929 1.4%
Holding current value
$281 Million
Previous $396 Million 1.38%
% of portfolio
0.28%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $5.42 Million - $6.36 Million
-5,291 Reduced 1.4%
371,638 $391 Million
Q2 2024

Aug 14, 2024

SELL
$883.2 - $1071.19 $26.6 Million - $32.3 Million
-30,129 Reduced 7.4%
376,929 $396 Million
Q1 2024

Apr 30, 2024

SELL
$902.69 - $993.35 $4.92 Million - $5.41 Million
-5,449 Reduced 1.32%
407,058 $392 Million
Q4 2023

Feb 01, 2024

SELL
$775.18 - $881.7 $6 Million - $6.82 Million
-7,737 Reduced 1.84%
412,507 $362 Million
Q3 2023

Nov 02, 2023

SELL
$692.45 - $844.37 $95.9 Million - $117 Million
-138,520 Reduced 24.79%
420,244 $346 Million
Q2 2023

Aug 09, 2023

SELL
$700.03 - $830.35 $10.5 Million - $12.5 Million
-15,048 Reduced 2.62%
558,764 $401 Million
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $26.7 Million - $32.5 Million
-39,264 Reduced 6.4%
573,812 $471 Million
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $91.9 Million - $99.7 Million
-130,121 Reduced 17.51%
613,076 $442 Million
Q3 2022

Nov 09, 2022

SELL
$573.97 - $724.32 $13 Million - $16.4 Million
-22,686 Reduced 2.96%
743,197 $512 Million
Q2 2022

Aug 10, 2022

SELL
$548.35 - $738.84 $5.51 Million - $7.43 Million
-10,057 Reduced 1.3%
765,883 $453 Million
Q1 2022

May 04, 2022

SELL
$595.12 - $698.43 $4.45 Million - $5.22 Million
-7,472 Reduced 0.95%
775,940 $542 Million
Q4 2021

Feb 10, 2022

SELL
$543.48 - $670.97 $10.5 Million - $12.9 Million
-19,267 Reduced 2.4%
783,412 $495 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $3.98 Million - $4.72 Million
6,929 Added 0.87%
802,679 $486 Million
Q2 2021

Aug 13, 2021

BUY
$472.8 - $558.54 $1.66 Million - $1.96 Million
3,514 Added 0.44%
795,750 $444 Million
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $16.3 Million - $19.9 Million
-36,387 Reduced 4.39%
792,236 $375 Million
Q4 2020

Feb 02, 2021

SELL
$478.3 - $607.98 $1.04 Million - $1.32 Million
-2,178 Reduced 0.26%
828,623 $400 Million
Q3 2020

Nov 05, 2020

SELL
$544.75 - $658.21 $3.92 Million - $4.74 Million
-7,197 Reduced 0.86%
830,801 $465 Million
Q2 2020

Aug 12, 2020

BUY
$493.32 - $643.92 $323 Million - $421 Million
654,007 Added 355.46%
837,998 $523 Million
Q1 2020

May 12, 2020

SELL
$336.18 - $494.43 $3.51 Million - $5.16 Million
-10,434 Reduced 5.37%
183,991 $89.8 Million
Q4 2019

Jan 27, 2020

BUY
$274.13 - $376.51 $2.9 Million - $3.99 Million
10,597 Added 5.76%
194,425 $73 Million
Q3 2019

Oct 31, 2019

BUY
$273.46 - $318.39 $13.9 Million - $16.2 Million
50,756 Added 38.14%
183,828 $51 Million
Q2 2019

Aug 15, 2019

SELL
$299.6 - $414.82 $2.78 Million - $3.84 Million
-9,263 Reduced 6.51%
133,072 $41.7 Million
Q1 2019

May 03, 2019

SELL
$372.08 - $439.57 $1.29 Million - $1.53 Million
-3,478 Reduced 2.39%
142,335 $58.4 Million
Q4 2018

Feb 08, 2019

SELL
$335.82 - $403.04 $6.49 Million - $7.79 Million
-19,328 Reduced 11.7%
145,813 $54.5 Million
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $4.32 Million - $5.02 Million
-12,294 Reduced 6.93%
165,141 $66.7 Million
Q2 2018

Aug 15, 2018

SELL
$284.6 - $344.99 $2.4 Million - $2.91 Million
-8,433 Reduced 4.54%
177,435 $61.2 Million
Q1 2018

May 11, 2018

BUY
$315.82 - $393.78 $293,396 - $365,821
929 Added 0.5%
185,868 $64 Million
Q4 2017

Feb 06, 2018

BUY
$358.63 - $469.95 $3.91 Million - $5.13 Million
10,910 Added 6.27%
184,939 $69.5 Million
Q3 2017

Nov 15, 2017

BUY
$431.38 - $504.0 $75.1 Million - $87.7 Million
174,029
174,029 $77.8 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.